Foreword |
|
xxiii | |
Preface |
|
xxv | |
Acknowledgments |
|
xxvii | |
Contributing Editors |
|
xxix | |
Contributors |
|
xxxi | |
Introduction |
|
|
1 Neurosurgical Abbreviations |
|
|
3 | (8) |
|
|
2 The Neurosurgery Candidate |
|
|
11 | (19) |
|
|
|
2.1 Gathering a Background in the Field |
|
|
11 | (2) |
|
2.2 Optimizing Clinical and Professional Skills |
|
|
13 | (7) |
|
2.3 The Application Process, Interview Season, and the Match |
|
|
20 | (10) |
|
3 Board Examinations in Neurosurgery |
|
|
30 | (6) |
|
|
|
3.1 U.S. (American Board of Neurological Surgery) |
|
|
30 | (2) |
|
3.2 European Written Board Examination |
|
|
32 | (1) |
|
3.3 Canadian Board Examination (Royal College of Physicians and Surgeons of Canada) |
|
|
33 | (3) |
|
4 Historical Pearls in Neurosurgery |
|
|
36 | (9) |
|
|
|
|
|
|
45 | (8) |
|
|
|
|
|
45 | (2) |
|
5.2 ACGME Hour Regulations for U.S. NSGY Residents |
|
|
47 | (2) |
|
5.3 ACGME Outcome Project |
|
|
49 | (4) |
|
|
53 | (6) |
|
|
|
|
53 | (3) |
|
|
56 | (3) |
|
7 Emergency Transfers---EMTALA |
|
|
59 | (3) |
|
|
|
|
62 | (6) |
|
|
|
|
62 | (1) |
|
8.2 Patient Insurance (Medicare/Medicaid/HMOs/PPOs) |
|
|
63 | (3) |
|
8.3 The Health Insurance Portability and Accountability Act (HIPAA) |
|
|
66 | (2) |
|
9 Ethics: Relationship with Vendors |
|
|
68 | (3) |
|
|
|
|
|
10 Focused Neurological Exam |
|
|
71 | (19) |
|
|
|
|
71 | (1) |
|
10.2 Level of Consciousness/Mental Status |
|
|
72 | (4) |
|
|
76 | (6) |
|
|
82 | (1) |
|
|
83 | (2) |
|
|
85 | (2) |
|
10.7 Coordination and Gait |
|
|
87 | (1) |
|
10.8 Neurological Examination of the Comatose Patient |
|
|
88 | (2) |
|
|
90 | (6) |
|
|
|
|
90 | (2) |
|
|
92 | (4) |
|
|
96 | (11) |
|
|
|
96 | (1) |
|
|
97 | (2) |
|
|
99 | (5) |
|
12.4 Work Environment Tips |
|
|
104 | (3) |
|
13 Oral Presentation Pearls |
|
|
107 | (4) |
|
|
|
14 Medical Spanish for Neurosurgeons |
|
|
111 | (7) |
|
|
|
|
111 | (1) |
|
|
112 | (1) |
|
14.3 Explaining Imaging Findings |
|
|
113 | (1) |
|
|
114 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
116 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
15 Neurosurgical Instruments |
|
|
118 | (15) |
|
|
|
|
|
|
133 | (33) |
|
|
|
16.1 Brainstem and Cranial Nerves |
|
|
133 | (5) |
|
|
133 | (3) |
|
|
136 | (1) |
|
|
136 | (2) |
|
|
138 | (3) |
|
|
141 | (2) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
143 | (1) |
|
16.4 Cerebral Hemispheres/Telencephalon |
|
|
143 | (5) |
|
|
144 | (1) |
|
|
145 | (3) |
|
16.5 Vascular Territories |
|
|
148 | (6) |
|
|
148 | (1) |
|
16.5.2 Anterior and Posterior Circulation |
|
|
149 | (5) |
|
16.5.3 Spinal Cord Blood Supply |
|
|
154 | (1) |
|
16.6 Spinal Cord and Tracts: Descending Pathways |
|
|
154 | (1) |
|
16.6.1 Corticospinal Tract |
|
|
154 | (1) |
|
16.6.2 Descending Autonomic System |
|
|
155 | (1) |
|
16.7 Spinal Cord and Tracts: Ascending Pathways |
|
|
155 | (3) |
|
16.7.1 Dorsal Columnar Pathway or Medial Lemniscal System |
|
|
155 | (2) |
|
16.7.2 Spinothalamic Tracts |
|
|
157 | (1) |
|
16.8 Autonomic Nervous System |
|
|
158 | (2) |
|
|
159 | (1) |
|
|
159 | (1) |
|
|
160 | (3) |
|
|
163 | (3) |
|
|
166 | (16) |
|
|
|
|
166 | (1) |
|
|
166 | (4) |
|
|
170 | (6) |
|
17.4 Evoked Potential Interpretation |
|
|
176 | (3) |
|
|
179 | (3) |
|
|
182 | (9) |
|
|
|
18.1 Neuronal Death and Regeneration |
|
|
182 | (1) |
|
18.2 Neuron/Axon Structure |
|
|
183 | (2) |
|
|
185 | (3) |
|
18.4 Muscle Spindles and Golgi Tendon Organs |
|
|
188 | (3) |
|
|
191 | (6) |
|
|
|
19.1 Circumventricular Organs |
|
|
191 | (1) |
|
|
191 | (4) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
19.2.5 Hypothalamic Input/Output Pathways |
|
|
193 | (2) |
|
19.3 Hypothalamus-Pituitary Axis |
|
|
195 | (2) |
|
|
197 | (33) |
|
|
|
|
|
|
197 | (16) |
|
|
197 | (5) |
|
20.1.2 "A Rosette by Any Other Name..." |
|
|
202 | (1) |
|
|
203 | (2) |
|
|
205 | (4) |
|
|
209 | (1) |
|
20.1.6 Immunohistochemistry |
|
|
210 | (3) |
|
20.2 Neurodegenerative Disorders |
|
|
213 | (7) |
|
|
213 | (2) |
|
20.2.2 Lewy Body Dementia |
|
|
215 | (1) |
|
|
215 | (1) |
|
|
216 | (1) |
|
20.2.5 Corticobasal Degeneration |
|
|
216 | (1) |
|
20.2.6 Multiple System Atrophy |
|
|
217 | (1) |
|
20.2.7 Creutzfeldt-Jakob Disease |
|
|
217 | (1) |
|
20.2.8 Friedreich's Ataxia |
|
|
218 | (1) |
|
20.2.9 Huntington's Disease |
|
|
219 | (1) |
|
20.2.10 Amyotrophic Lateral Sclerosis |
|
|
219 | (1) |
|
20.3 Demyelinating Disorders |
|
|
220 | (4) |
|
20.3.1 Multiple Sclerosis |
|
|
220 | (3) |
|
20.3.2 Other Demyelinating Disorders |
|
|
223 | (1) |
|
|
224 | (2) |
|
|
226 | (4) |
|
|
230 | (19) |
|
|
|
|
21.1 Eight-Point Exam and Visual Acuity |
|
|
230 | (2) |
|
|
232 | (1) |
|
|
233 | (5) |
|
|
238 | (8) |
|
21.5 Visual Fields and the Visual System |
|
|
246 | (3) |
|
|
249 | (7) |
|
|
|
|
249 | (3) |
|
22.2 Audiogram and Audiology Examination |
|
|
252 | (4) |
|
|
256 | (19) |
|
|
|
|
256 | (3) |
|
23.1.1 Important Lines and Planes |
|
|
256 | (1) |
|
23.1.2 Important Measurements and Indexes |
|
|
257 | (2) |
|
23.2 CT, Xenon (Xe)-CT, CT Angiography (CTA) |
|
|
259 | (3) |
|
|
262 | (1) |
|
23.4 MRI/MR Angiography (MRA)/Functional MRI (fMRI) |
|
|
262 | (2) |
|
23.5 MRI Sequences (T1, T2, FLAIR, DWI, ADC, EG, SWI) |
|
|
264 | (1) |
|
23.6 Magnetic Resonance Spectroscopy (MRS) |
|
|
265 | (4) |
|
|
269 | (6) |
|
|
|
|
275 | (9) |
|
|
|
|
|
|
|
|
275 | (1) |
|
|
276 | (4) |
|
24.3 Tension-Type Headaches |
|
|
280 | (1) |
|
24.4 Cluster and Other Dysautonomic Cephalalgias |
|
|
280 | (1) |
|
24.5 Low-Pressure Headaches |
|
|
281 | (3) |
|
|
284 | (7) |
|
|
|
|
|
|
|
|
284 | (1) |
|
|
285 | (1) |
|
|
286 | (2) |
|
|
288 | (3) |
|
|
291 | (7) |
|
|
|
|
|
|
|
|
291 | (1) |
|
|
292 | (2) |
|
26.3 Vascular-Related Cognitive Impairment |
|
|
294 | (1) |
|
26.4 Frontotemporal Lobar Degeneration |
|
|
295 | (1) |
|
26.5 Dementia with Lewy Bodies (DLB) |
|
|
296 | (2) |
|
27 Cerebrovascular Disease |
|
|
298 | (5) |
|
|
|
|
|
|
|
|
298 | (2) |
|
|
300 | (1) |
|
|
301 | (2) |
|
|
303 | (5) |
|
|
|
|
|
|
|
29 Motor and Demyelinating Disorders |
|
|
308 | (14) |
|
|
|
|
|
|
|
29.1 Amyotrophic Lateral Sclerosis |
|
|
308 | (2) |
|
|
310 | (2) |
|
|
312 | (2) |
|
29.4 Guillain-Barre Syndrome |
|
|
314 | (2) |
|
|
316 | (1) |
|
29.6 Myopathy and Muscle Disorders |
|
|
317 | (5) |
|
30 Vasculitis and Paraneoplastic Syndromes |
|
|
322 | (8) |
|
|
|
|
|
|
|
|
322 | (3) |
|
30.2 Paraneoplastic Syndromes |
|
|
325 | (5) |
|
31 Infections in the Nervous System |
|
|
330 | (21) |
|
|
|
|
|
|
|
|
330 | (3) |
|
31.2 Bacterial Meningitis |
|
|
333 | (3) |
|
|
336 | (1) |
|
31.4 Spirochetal Meningitis |
|
|
337 | (1) |
|
31.5 Protozoal and Helminthic Meningitis |
|
|
338 | (1) |
|
|
339 | (1) |
|
|
340 | (2) |
|
|
342 | (1) |
|
|
343 | (2) |
|
31.10 Parasitic Infections |
|
|
345 | (1) |
|
31.11 Perioperative Infections/Prophylactic Antibiotics |
|
|
346 | (5) |
|
|
|
|
351 | (25) |
|
|
|
|
|
|
32.1 Basic Concepts: Consciousness |
|
|
351 | (1) |
|
32.2 Grades of Consciousness |
|
|
352 | (8) |
|
32.3 Electrolyte/Metabolic |
|
|
360 | (1) |
|
|
361 | (3) |
|
|
364 | (2) |
|
|
366 | (1) |
|
|
367 | (5) |
|
|
372 | (1) |
|
|
372 | (1) |
|
32.10 Encephalopathic Coma |
|
|
373 | (3) |
|
|
376 | (11) |
|
|
|
|
|
|
|
376 | (2) |
|
33.2 Testing for Brain Death |
|
|
378 | (2) |
|
33.3 Certification of Brain Death |
|
|
380 | (1) |
|
|
381 | (1) |
|
33.5 Ethical and Legal Issues in Brain Death |
|
|
381 | (2) |
|
33.6 High-Yield Coma Facts |
|
|
383 | (4) |
|
|
|
|
387 | (5) |
|
|
|
|
|
|
|
387 | (2) |
|
34.2 Karnofsky Performance Scale (KPS) |
|
|
389 | (1) |
|
|
390 | (2) |
|
|
392 | (76) |
|
|
|
|
|
|
|
392 | (66) |
|
|
392 | (1) |
|
|
392 | (1) |
|
35.1.1.2 Low-Grade Astrocytoma |
|
|
393 | (9) |
|
35.1.1.3 Oligodendroglioma |
|
|
402 | (5) |
|
35.1.1.4 Oligoastrocytoma |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
407 | (2) |
|
35.1.2.2 Anaplastic Astrocytoma |
|
|
409 | (1) |
|
35.1.2.3 Glioblastoma (GBM) |
|
|
410 | (6) |
|
35.1.2.4 Gliomatosis Cerebri |
|
|
416 | (1) |
|
|
417 | (7) |
|
35.1.4 Pineal Region and Intraventricular Tumors |
|
|
424 | (1) |
|
|
424 | (2) |
|
|
426 | (4) |
|
35.1.4.3 Choroid Plexus Tumors |
|
|
430 | (2) |
|
35.1.4.4 Germ Cell Tumors |
|
|
432 | (4) |
|
35.1.4.5 Pineal Region Tumors |
|
|
436 | (2) |
|
35.1.5 Nerve Sheath Tumors |
|
|
438 | (1) |
|
|
438 | (1) |
|
|
438 | (6) |
|
|
444 | (1) |
|
|
445 | (2) |
|
35.1.5.5 Malignant Peripheral Nerve Sheath Tumor |
|
|
447 | (1) |
|
|
448 | (1) |
|
|
448 | (1) |
|
|
449 | (5) |
|
35.1.6.3 Central Nervous System Primitive Neuroectodermal Tumors |
|
|
454 | (2) |
|
35.1.6.4 Atypical Teratoid/Rhabdoid Tumor (AT/RT) |
|
|
456 | (2) |
|
|
458 | (4) |
|
|
462 | (6) |
|
|
468 | (10) |
|
|
|
|
|
|
|
468 | (2) |
|
36.2 Intradural Extramedullary |
|
|
470 | (1) |
|
36.3 Intradural Intramedullary |
|
|
471 | (5) |
|
36.4 Lesion Distributions |
|
|
476 | (2) |
|
37 Phakomatoses and Neurocutaneous Disorders |
|
|
478 | (23) |
|
|
|
37.1 Neurofibromatosis Type 1 (NF1) |
|
|
478 | (4) |
|
37.2 Neurofibromatosis Type 2 (NF2) |
|
|
482 | (3) |
|
|
485 | (1) |
|
37.4 Von Hippel-Lindau Syndrome (VHL) |
|
|
485 | (3) |
|
37.5 Tuberous Sclerosis Complex |
|
|
488 | (3) |
|
37.6 Sturge-Weber Syndrome (SWS) |
|
|
491 | (2) |
|
|
493 | (1) |
|
|
494 | (1) |
|
37.9 Rhabdoid Predisposition Syndrome |
|
|
494 | (1) |
|
37.10 Hereditary Hemorrhagic Telangiectasia (HHT) |
|
|
495 | (6) |
|
|
|
|
501 | (7) |
|
|
|
|
|
|
38.1 Important Terminology and Concepts |
|
|
501 | (1) |
|
|
502 | (1) |
|
38.3 Radiation Delivery Options (Whole Brain, Fractionated Radiosurgery, Stereotactic Radiosurgery) |
|
|
502 | (6) |
|
39 Radiosurgical Techniques |
|
|
508 | (13) |
|
|
|
|
|
|
39.1 Procedure Pearls and Frame Placement |
|
|
508 | (4) |
|
39.2 Preprocedure Planning |
|
|
512 | (2) |
|
39.3 Clinical Application Concepts |
|
|
514 | (1) |
|
39.4 Postprocedure Complications and Management |
|
|
515 | (6) |
|
NEUROENDOCRINE AND PITUITARY |
|
|
|
40 Neuroendocrine Disorders |
|
|
521 | (22) |
|
|
|
|
|
|
40.1 Neuroendocrine Sodium Abnormalities |
|
|
521 | (2) |
|
|
523 | (4) |
|
|
527 | (8) |
|
|
535 | (1) |
|
|
536 | (1) |
|
40.6 Syndrome of Inappropriate Antidiuretic Hormone (SIADH) |
|
|
536 | (2) |
|
40.7 Diabetes Insipidus (DI) |
|
|
538 | (1) |
|
40.8 Cerebral Salt Wasting (CSW) |
|
|
539 | (4) |
|
|
543 | (32) |
|
|
|
|
|
|
|
543 | (12) |
|
41.2 Preoperative Assessment |
|
|
555 | (1) |
|
41.3 History and Physical Examination Pearls |
|
|
556 | (2) |
|
|
558 | (5) |
|
41.5 Operative Approaches |
|
|
563 | (6) |
|
41.6 Postoperative Management |
|
|
569 | (6) |
|
|
|
42 Cavernous Sinus Anatomy |
|
|
575 | (2) |
|
|
|
|
577 | (5) |
|
|
|
44 Skull Base Approaches and Targets |
|
|
582 | (17) |
|
|
|
44.1 General Operative Principles |
|
|
582 | (1) |
|
44.2 Anterior Fossa: The Subfrontal Approach |
|
|
583 | (1) |
|
|
584 | (5) |
|
44.3.1 The Middle Fossa Approach |
|
|
584 | (2) |
|
44.3.2 The Cranio-Orbitozygomatic Approach |
|
|
586 | (2) |
|
44.3.3 The Petrosal Approach (Anterior, Posterior and Combined) |
|
|
588 | (1) |
|
44.4 Posterior Fossa and Craniocervical Junction |
|
|
589 | (10) |
|
44.4.1 Acoustic Schwannomas and the Retrosigmoid Approach |
|
|
589 | (2) |
|
44.4.2 The Far Lateral Approach |
|
|
591 | (3) |
|
44.4.3 The Transoral Approach |
|
|
594 | (5) |
|
|
|
45 Structural and Functional Anatomy |
|
|
599 | (6) |
|
|
|
|
599 | (3) |
|
|
602 | (3) |
|
|
605 | (16) |
|
|
|
46.1 Classification of Fractures and Mechanisms of Injury |
|
|
605 | (2) |
|
46.2 Atlanto-Occipital Dislocation |
|
|
607 | (1) |
|
|
608 | (2) |
|
|
610 | (3) |
|
46.5 Jumped and Perched Facets |
|
|
613 | (2) |
|
|
615 | (1) |
|
|
615 | (3) |
|
46.8 Compression Fractures |
|
|
618 | (3) |
|
|
621 | (7) |
|
|
|
|
621 | (1) |
|
47.2 National Spinal Cord Injury Study |
|
|
622 | (1) |
|
47.3 Central Cord Syndrome |
|
|
622 | (3) |
|
47.4 Anterior and Posterior Cord Syndromes |
|
|
625 | (1) |
|
47.5 Brown-Sequard Syndrome |
|
|
626 | (2) |
|
48 Degenerative Spine Disease |
|
|
628 | (16) |
|
|
|
48.1 Cervical Disk Herniation |
|
|
628 | (2) |
|
48.2 Thoracic Herniated Disk |
|
|
630 | (1) |
|
48.3 Degenerative Disk Disease and Lower Back Pain |
|
|
631 | (8) |
|
48.4 Cauda Equina Syndrome (CES) |
|
|
639 | (1) |
|
48.5 Spondylolisthesis and Spinal Instability |
|
|
640 | (4) |
|
|
644 | (3) |
|
|
|
|
644 | (1) |
|
|
644 | (1) |
|
|
645 | (1) |
|
|
646 | (1) |
|
|
647 | (4) |
|
|
|
|
|
51 Intracranial Aneurysms |
|
|
651 | (9) |
|
|
|
|
|
52 Subarachnoid Hemorrhage and Vasospasm |
|
|
660 | (7) |
|
|
|
|
|
|
667 | (10) |
|
|
|
|
|
54 Vascular Malformations |
|
|
677 | (10) |
|
|
|
|
|
55 Cerebro-Occlusive Disease |
|
|
687 | (10) |
|
|
|
|
|
55.1 Carotid Arterial Stenosis |
|
|
687 | (2) |
|
|
689 | (1) |
|
|
690 | (7) |
|
|
|
56 Traumatic Brain Injury (TBI) |
|
|
697 | (24) |
|
|
|
|
|
697 | (2) |
|
|
699 | (3) |
|
|
702 | (2) |
|
56.4 Traumatic Intraparenchymal Hemorrhage |
|
|
704 | (1) |
|
|
705 | (1) |
|
|
706 | (2) |
|
56.7 Surgical Pearls in Acute SDH |
|
|
708 | (2) |
|
56.8 Chronic Subdural Hematoma |
|
|
710 | (4) |
|
|
714 | (1) |
|
56.10 Late Complications of TBI |
|
|
714 | (7) |
|
|
|
|
721 | (26) |
|
|
|
|
721 | (1) |
|
|
722 | (2) |
|
|
724 | (1) |
|
|
725 | (6) |
|
57.5 Advanced Neuromonitoring |
|
|
731 | (2) |
|
|
733 | (1) |
|
57.7 Fluid and Electrolytes |
|
|
734 | (2) |
|
57.8 Pulmonary Complications |
|
|
736 | (1) |
|
57.9 Coagulation and Deep Venous Thrombosis |
|
|
737 | (1) |
|
|
738 | (2) |
|
|
740 | (1) |
|
57.12 Neurocritical Care Case Studies |
|
|
741 | (6) |
|
|
|
|
747 | (3) |
|
|
|
|
747 | (1) |
|
58.2 Phases of Anesthesia |
|
|
747 | (2) |
|
|
749 | (1) |
|
59 Pharmacological Aspects |
|
|
750 | (5) |
|
|
|
|
750 | (2) |
|
59.2 Particular Considerations |
|
|
752 | (3) |
|
60 Monitoring During Anesthesia |
|
|
755 | (2) |
|
|
|
|
755 | (1) |
|
60.2 Cerebral Oxygenation |
|
|
755 | (2) |
|
61 Considerations for Neurosurgical Patients |
|
|
757 | (6) |
|
|
|
|
757 | (1) |
|
|
757 | (1) |
|
61.3 Important Miscellaneous Things to Remember |
|
|
758 | (5) |
|
|
|
|
763 | (25) |
|
|
|
|
|
|
763 | (1) |
|
|
764 | (2) |
|
|
766 | (1) |
|
62.4 Trigeminal Neuralgia |
|
|
767 | (11) |
|
62.5 Glossopharyngeal Neuralgia |
|
|
778 | (1) |
|
|
779 | (2) |
|
62.7 Complex Regional Pain Syndrome (CRPS) |
|
|
781 | (3) |
|
62.8 Peripheral Nerve Stimulation for Neuropathic Pain |
|
|
784 | (4) |
|
|
788 | (12) |
|
|
|
|
|
63.1 Pathophysiology: Seizure Focus |
|
|
788 | (1) |
|
|
788 | (6) |
|
63.3 Intraoperative Recordings |
|
|
794 | (1) |
|
|
795 | (2) |
|
63.5 Epilepsy Surgery: Neuromodulation |
|
|
797 | (3) |
|
|
800 | (17) |
|
|
|
|
|
64.1 History of Deep Brain Stimulation in Parkinson's Disease |
|
|
800 | (2) |
|
64.2 Diagnosis and Medical Management |
|
|
802 | (1) |
|
|
803 | (1) |
|
64.4 Targets and Pathways |
|
|
804 | (3) |
|
64.5 Indications and Pathophysiology |
|
|
807 | (10) |
|
|
|
|
817 | (3) |
|
|
|
|
|
|
|
820 | (9) |
|
|
|
|
|
|
|
820 | (6) |
|
|
826 | (3) |
|
|
829 | (3) |
|
|
|
|
|
|
68 Common Entrapment Neuropathies |
|
|
832 | (9) |
|
|
|
|
|
|
69 Peripheral Nerve Grafting and Repair |
|
|
841 | (6) |
|
|
|
|
|
|
|
|
70 General Considerations |
|
|
847 | (10) |
|
|
|
|
|
|
847 | (2) |
|
70.2 Fontanelles and Sutures |
|
|
849 | (1) |
|
70.3 Examination of the Pediatric Population |
|
|
849 | (8) |
|
|
857 | (14) |
|
|
|
|
|
|
857 | (1) |
|
|
858 | (2) |
|
|
860 | (5) |
|
|
865 | (1) |
|
|
865 | (6) |
|
72 Other Craniofacial and Spinal Malformations |
|
|
871 | (35) |
|
|
|
|
|
72.1 Arachnoid Cyst (Intracranial) |
|
|
871 | (4) |
|
72.2 Neurenteric Cyst (Intraspinal) |
|
|
875 | (2) |
|
72.3 Neuronal Migration Disorders |
|
|
877 | (4) |
|
72.4 Holoprosencephaly (HPE) |
|
|
881 | (2) |
|
72.5 Chiari Malformations |
|
|
883 | (10) |
|
|
893 | (4) |
|
|
897 | (9) |
|
|
906 | (16) |
|
|
|
|
|
|
906 | (3) |
|
73.2 Occult Spinal Dysraphism |
|
|
909 | (7) |
|
|
916 | (2) |
|
73.4 Klippel-Feil Syndrome |
|
|
918 | (4) |
|
74 Child-Abuse: Nonaccidental Trauma |
|
|
922 | (9) |
|
|
|
|
|
|
|
|
931 | (3) |
|
|
|
76 Types of Hydrocephalus |
|
|
934 | (10) |
|
|
|
|
944 | (11) |
|
|
|
|
944 | (2) |
|
|
946 | (3) |
|
|
949 | (6) |
|
|
|
|
955 | (16) |
|
|
|
|
Index |
|
971 | |